These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2475253)

  • 1. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
    Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
    G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medium term study of the efficacy of propafenone in the treatment of hyperkinetic ventricular arrhythmia].
    Cairo GF; Zanni PP; Mascelli G; Zangara A
    Clin Ter; 1989 Jun; 129(5):353-7. PubMed ID: 2527666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy].
    Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F
    G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propafenone in the treatment of high-risk ventricular arrhythmias].
    Pepi R; Rotatori D; Mori A; Nascimbeni F
    Clin Ter; 1986 Aug; 118(4):247-52. PubMed ID: 3757464
    [No Abstract]   [Full Text] [Related]  

  • 10. [Propafenone per os in ventricular arrhythmia].
    Colas A; Maarek-Charbit M
    Cah Anesthesiol; 1989; 37(4):241-4. PubMed ID: 2790548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propafenone for malignant ventricular arrhythmia: an analysis of the literature.
    Hernandez M; Reder RF; Marinchak RA; Rials SJ; Kowey PR
    Am Heart J; 1991 Apr; 121(4 Pt 1):1178-84. PubMed ID: 2008842
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
    Câmpeanu A; Rădoi M; Serban-Pârâu G; Pleşca O; Nuţă M; Teodorescu V; Titirigă M
    Med Interna; 1993; 45(1-2):35-41. PubMed ID: 8081689
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polycardiographic evaluation of the dynamics of left ventricular contraction in patients treated with disopyramide and propafenone].
    Tomaszewski A; Kleinrok A; Rumiński W; Markiewicz M
    Wiad Lek; 1986 Dec; 39(23):1585-91. PubMed ID: 2438848
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.
    Frabetti L; Marchesini B; Capucci A; Cavallini C; Gubelli S; Ambrosioni E; Magnani B
    Eur J Clin Pharmacol; 1986; 30(6):665-71. PubMed ID: 2429844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
    Mondillo S; Faglia S; D'Aprile N; Mangiacotti L; Campolo MA; Agricola E; Palazzuoli V
    Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses].
    Lardoux H; Valère PE; Djiane P; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):281-8. PubMed ID: 7690219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propafenone. An antiarrhythmic agent for both ventricular and supraventricular arrhythmia].
    Madsen JK; Nielsen H; Madsen BK
    Ugeskr Laeger; 1988 Dec; 150(50):3132-3. PubMed ID: 3206724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.